EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5

Lawrence T Wang, Andrew J R Cooper, Brendan Farrell, Kazutoyo Miura, Ababacar Diouf, Nicole Müller-Sienerth, Cécile Crosnier, Lauren Purser, Payton J Kirtley, Maciej Maciuszek, Jordan R Barrett, Kirsty McHugh und 25 weitere

Cell · 2024-09 · 187 (18) · 4981-4995.e14

DOI: 10.1016/j.cell.2024.06.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-09. Verfasst von Lawrence T Wang und 36 weiteren Autor:innen. Beteiligte Einrichtung: Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville,…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Plasmodium falciparum, Malaria, Falciparum, Malaria Vaccines. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Institute of Allergy and Infectious Diseases Division of Intramural Research, USAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) is the most advanced blood-stage malaria vaccine candidate and is being evaluated for efficacy in endemic regions, emphasizing the need to study the underlying antibody response to RH5 during natural infection, which could augment or counteract responses to vaccination. Here, we found that RH5-reactive B cells were rare, and circulating immunoglobulin G (IgG) responses to RH5 were short-lived in malaria-exposed Malian individuals, despite repeated infections over multiple years. RH5-specific monoclonal antibodies isolated from eight malaria-exposed individuals mostly targeted non-neutralizing epitopes, in contrast to antibodies isolated from five RH5-vaccinated, malaria-naive UK individuals. However, MAD8-151 and MAD8-502, isolated from two malaria-exposed Malian individuals, were among the most potent neutralizers out of 186 antibodies from both cohorts and targeted the same epitopes as the most potent vaccine-induced antibodies. These results suggest that natural malaria infection may boost RH5-vaccine-induced responses and provide a clear strategy for the development of next-generation RH5 vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingPlasmodium falciparumMalaria, FalciparumMalaria VaccinesAntibodies, ProtozoanAntigens, ProtozoanHumansImmunoglobulin GProtozoan ProteinsAntibodies, MonoclonalAdultB-LymphocytesEpitopesFemaleMaliCarrier ProteinsMaleAdolescent

Stichwörter der Autor:innen

Plasmodium falciparumRH5malariamonoclonal antibodiesnatural infectionvaccine design

Substanzen

Antibodies, NeutralizingMalaria VaccinesRH5 protein, Plasmodium falciparumAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin GProtozoan ProteinsAntibodies, MonoclonalEpitopesCarrier Proteins

Autor:innen und Institutionen

  • Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA; Vaccine Research Center, National Institute of Allergy…
  • Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
  • Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3Q…
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
  • Wellcome Sanger Institute, Cambridge CB10 1SA, UK.
  • Department of Biology, Hull York Medical School, York Biomedical Research Institute, University of York, Heslington, York YO10 5DD, UK.

Förderung

  • Wellcome Trust
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research
  • USAID
  • U.S. Department of Health and Human Services
  • Vaccine Research Center
  • Silver Family Foundation
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Wang, L. T., Cooper, A. J. R., Farrell, B., Miura, K., Diouf, A., Müller-Sienerth, N., Crosnier, C., Purser, L., Kirtley, P. J., Maciuszek, M., Barrett, J. R., McHugh, K., Ogwang, R., Tucker, C., Li, S., Doumbo, S., Doumtabe, D., Pyo, C. W., Skinner, J., …, & Tan, J. (2024). Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell, 187(18), 4981-4995.e14. https://doi.org/10.1016/j.cell.2024.06.037

Vancouver

Wang LT, Cooper AJR, Farrell B, Miura K, Diouf A, Müller-Sienerth N, et al. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5. Cell. 2024;187(18):4981-4995.e14. doi:10.1016/j.cell.2024.06.037

BibTeX
@article{Wang2024,
  author = {Wang, Lawrence T and Cooper, Andrew J R and Farrell, Brendan and Miura, Kazutoyo and Diouf, Ababacar and Müller-Sienerth, Nicole and Crosnier, Cécile and Purser, Lauren and Kirtley, Payton J and Maciuszek, Maciej and Barrett, Jordan R and McHugh, Kirsty and Ogwang, Rodney and Tucker, Courtney and Li, Shanping and Doumbo, Safiatou and Doumtabe, Didier and Pyo, Chul-Woo and Skinner, Jeff and Nielsen, Carolyn M and Silk, Sarah E and Kayentao, Kassoum and Ongoiba, Aissata and Zhao, Ming and Nguyen, Doan C and Lee, F Eun-Hyung and Minassian, Angela M and Geraghty, Daniel E and Traore, Boubacar and Seder, Robert A and Wilder, Brandon K and Crompton, Peter D and Wright, Gavin J and Long, Carole A and Draper, Simon J and Higgins, Matthew K and Tan, Joshua},
  title = {Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {18},
  pages = {4981--4995.e14},
  doi = {10.1016/j.cell.2024.06.037}
}
Kostenlos starten →